If you have type 2 diabetes, your health care provider may recommend Victoza (liraglutide) or Ozempic (semaglutide) to help ...

Patients injecting compounded semaglutide for weight loss are overdosing at alarming rates, flooding poison control centers ...

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Carley ...

People taking popular weight-loss drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound may be losing pounds, but they could also be moving less. Researchers analyzing Fitbit data found that daily ...

Tap Here To Add Us Weekly As A Trusted Source Add as a preferred source on Google Maybe the cost of Ozempic finally got to you. Maybe the nausea never really went away, or you hit your goal weight and ...

A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer. Researchers say the ...

When scientists first discovered the insulin secretion effects of gut hormone GLP-1 in the 1980s, it seemed like the automatic gateway toward a landmark diabetes treatment. GLP-1, or glucagon-like ...

TORONTO, May 14, 2026 /CNW/ - Apotex Inc. ("Apotex" or the "Company"), the largest Canadian‑based global health company, today announced the commercial launch of Apo‑Semaglutide Injection™ – a generic ...

Apo-Semaglutide Injection™ is administered using a prefilled pen with instructions for use consistent with brand‑name semaglutide, supporting familiarity for patients and health care professionals, ...

Credit: Novo Nordisk. The newly approved oral formulation features a smaller pill size in 1.5mg, 4mg, and 9mg strengths while maintaining the efficacy and safety profile of the previous oral ...

The semaglutide franchise is changing up its branding as Novo Nordisk, seeing the cultural phenomenon that has become Ozempic, is retiring the Rybelsus name in favor of its better-known brand. Meet ...

Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...